These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7040254)

  • 1. In vitro augmentation of human natural killer (NK) cell activity by a streptococcal preparation OK-432 and its extracts, protein M and polysaccharides.
    Wakasugi H; Oshimi K; Kasahara T; Miyata M; Morioka Y
    Int Arch Allergy Appl Immunol; 1982; 67(4):322-8. PubMed ID: 7040254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
    Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
    J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
    Bonavida B; Katz J; Hoshino T
    Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
    Wakasugi H; Oshimi K; Miyata M; Morioka Y
    J Clin Immunol; 1981 Jul; 1(3):154-62. PubMed ID: 6174541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent.
    Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Yoshida H; Matsuno T; Saito M; Sato M
    Immunopharmacology; 2000 Sep; 49(3):363-76. PubMed ID: 10996034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro augmentation of natural killing activity by OK-432.
    Uchida A; Micksche M
    Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-gamma.
    Bonavida B; Jewett A
    Cell Immunol; 1989 Oct; 123(2):373-83. PubMed ID: 2507170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OK-432 and IL-2-augmented cytotoxicity of human natural killer cells and cytotoxic T lymphocytes at the clonal level.
    Gravekamp C; Vreugdenhil R; Bolhuis RL
    FEMS Microbiol Immunol; 1988 Jan; 1(1):31-9. PubMed ID: 2978812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K; Ichimura O; Mitsuno T; Osawa T
    J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced generation of OK-432-induced killer cells by interleukin 2.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):183-8. PubMed ID: 3500332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H; Reynolds CW
    J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K; Kano S; Takaku F; Okumura K
    J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
    Huang XL; Fan Z; Murayama T; Rinaldo C
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
    Christmas SE; Meager A; Moore M
    Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction by OK-432 of the monolayer contact-mediated inhibition of human natural killer cell activity.
    Yagita M; Saksela E
    Immunol Lett; 1990 Sep; 25(4):347-53. PubMed ID: 2249878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of mouse natural killer cell activity by combined hyperthermia and streptococcal preparation, OK-432 (Picibanil) treatment.
    Taradi M; Urano M; Taradi SK; Maruyama Y
    Int J Hyperthermia; 1991; 7(4):653-65. PubMed ID: 1919160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432].
    Hoshino T; Uchida A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1277-84. PubMed ID: 3488024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of natural killer activity and augmentation by OK-432 in patients with gynecological malignancies.
    Negishi Y; Miura M; Saito M; Sano Y; Akiya K; Fujiwara Y
    Gynecol Obstet Invest; 1986; 21(1):40-6. PubMed ID: 3485072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.